Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Spironolactone plus finasteride works better for treating hirsutism.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Balding and low testosterone increase risk of urinary stones.

Finasteride helps induce ovulation in nonresponder PCOS women.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

PCOS affects many young women in KSA, with mild cases being most common.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Older men with lower levels of available testosterone are more likely to be frail.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.